<VariationArchive RecordType="classified" VariationID="2581131" VariationName="NM_000341.4(SLC3A1):c.1431_1434dup (p.Tyr479fs)" VariationType="Duplication" Accession="VCV002581131" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-07" DateCreated="2023-10-07" MostRecentSubmission="2023-10-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2748713" VariationID="2581131">
      <GeneList>
        <Gene Symbol="SLC3A1" FullName="solute carrier family 3 member 1" GeneID="6519" HGNC_ID="HGNC:11025" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="44275480" stop="44322437" display_start="44275480" display_stop="44322437" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="44502596" stop="44547962" display_start="44502596" display_stop="44547962" Strand="+" />
          </Location>
          <OMIM>104614</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000341.4(SLC3A1):c.1431_1434dup (p.Tyr479fs)</Name>
      <CanonicalSPDI>NC_000002.12:44312682:TAACT:TAACTAACT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="44312682" stop="44312683" display_start="44312682" display_stop="44312683" variantLength="4" positionVCF="44312682" referenceAlleleVCF="A" alternateAlleleVCF="ATAAC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="44539821" stop="44539822" display_start="44539821" display_stop="44539822" variantLength="4" positionVCF="44539821" referenceAlleleVCF="A" alternateAlleleVCF="ATAAC" />
      </Location>
      <ProteinChange>Y479fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.44539823_44539826dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.44539823_44539826dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.44312684_44312687dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.44312684_44312687dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008233.1" sequenceAccession="NG_008233" sequenceVersion="1" change="g.42227_42230dup">
            <Expression>NG_008233.1:g.42227_42230dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000341.4" sequenceAccession="NM_000341" sequenceVersion="4" change="c.1431_1434dup" MANESelect="true">
            <Expression>NM_000341.4:c.1431_1434dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000332.2" sequenceAccession="NP_000332" sequenceVersion="2" change="p.Tyr479fs">
            <Expression>NP_000332.2:p.Tyr479fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000341.4" sequenceAccession="NM_000341" sequenceVersion="4" change="c.1431_1434dupAACT" MANESelect="true">
            <Expression>NM_000341.4:c.1431_1434dupAACT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000341.4(SLC3A1):c.1431_1434dup (p.Tyr479fs) AND Cystinuria" Accession="RCV003330373" Version="1">
        <ClassifiedConditionList TraitSetID="1615">
          <ClassifiedCondition DB="MedGen" ID="C0010691">Cystinuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-06-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-10-07" MostRecentSubmission="2023-10-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1615" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1217" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CYSTINURIA, TYPE I</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYSTINURIA, TYPE II</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYSTINURIA, TYPE III</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cystinuria</ElementValue>
                <XRef ID="22232" DB="GeneTests" />
                <XRef ID="Cystinuria/2081" DB="Genetic Alliance" />
                <XRef ID="HP:0003131" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0009067" DB="MONDO" />
                <XRef ID="85020001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinuria, non-type I</ElementValue>
                <XRef ID="UWMG_9204648" DB="CSER _CC_NCGL, University of Washington" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CSNU</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CSNU1</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CSNU3</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6237" />
                <XRef ID="6237" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cystinuria is an autosomal disorder characterized by impaired epithelial cell transport of cystine and dibasic amino acids (lysine, ornithine, and arginine) in the proximal renal tubule and gastrointestinal tract. The impaired renal reabsorption of cystine and its low solubility causes the formation of calculi in the urinary tract, resulting in obstructive uropathy, pyelonephritis, and, rarely, renal failure (summary by Barbosa et al., 2012).</Attribute>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21863055</ID>
              </Citation>
              <XRef ID="214" DB="Orphanet" />
              <XRef ID="C0010691" DB="MedGen" />
              <XRef ID="MONDO:0009067" DB="MONDO" />
              <XRef Type="MIM" ID="220100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003131" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7556266" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="CV-FR-00008|OMIM:220100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004037473" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="Clinical Genetics, Synlab MVZ Humangenetik Freiburg" OrgID="509036" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SLC3A1 variant c.1431_1434dupAACT, p.(Tyr479Asnfs*19), has not yet been described, but it is known that "loss-of-function" is a known pathomechanism in the SLC3A1 gene, e.g., c.1754_1755delAG, p.(Glu585Alafs*24) (Gaildrat et al. 2017 and HGMD Professional 2023.1, among others). The variant is not listed in control databases (dbSNP, gnomAD v2.1.1). It is a reading frame mutation that leads to premature translational arrest and thus either loss of function of the affected allele due to premature degradation of the mutant mRNA or to a truncated protein with reduced or aberrant function. We classify the SLC3A1 variant c.1431_1434dupAACT, p.(Tyr479Asnfs*19), as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">tubular renal cystinuria</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC3A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000341.4:c.1431_1434dupAACT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13877117</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7556266" TraitType="Disease" MappingType="XRef" MappingValue="220100" MappingRef="OMIM">
        <MedGen CUI="C0010691" Name="Cystinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7556266" TraitType="Finding" MappingType="Name" MappingValue="tubular renal cystinuria" MappingRef="Preferred">
        <MedGen CUI="None" Name="tubular renal cystinuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

